国家卫生健康委联合工业和信息化部、国家知识产权局、国家医保局、国家药监局等部门印发第四批鼓励仿制药品目录

Core Viewpoint - The National Health Commission, in collaboration with several government departments, has issued the fourth batch of encouraged generic drug lists, indicating a continued push for the development and use of generic medications in the healthcare sector [1] Group 1 - The issuance of the fourth batch of encouraged generic drugs aims to enhance the availability of affordable medications [1] - This initiative involves multiple government agencies, including the Ministry of Industry and Information Technology, the National Intellectual Property Administration, the National Medical Insurance Administration, and the National Medical Products Administration, highlighting a coordinated effort to support the generic drug industry [1]